GTC Biotherapeutics (fka GTCB)

[vinmantoo]

It is nice to see the US launch. This is some small bit of good news finally. It only took 4 months after FDA approval for Ovation/Lundbeck to get ATRYN on the market in the entire USA. In contrast, the horrid European partner LEO took 1 1/3 year to get ATRYN for sales and then only in England. GTCB should include this in their lawsuit against LEO for damages. What would be better is Lundbeck announcing the phase III trials for ATRYN in CABG and initiation of DIC trials in the US. Of course, I would like to see European rights finally transferred to a new partner and DIC trials restarted there.